Skip to main content

Table 2 Demographic and clinical data of diabetic subjects with and without MACE

From: Association between omentin-1 and major cardiovascular events after lower extremity endovascular revascularization in diabetic patients: a prospective cohort study

 

NO MACE (n = 123)

MACE (n = 84)

p value

Age, years

75.244

74.584

0.606

Men:women, n

79:44

65:19

0.043

BMI, kg/m2

26.712

26.729

0.858

Diabetes duration, years

11.463

11.373

0.463

HBP, n (%)

81 (65.9)

63 (75.0)

0.160

HCHOL, n (%)

64 (52,0)

49 (58.3)

0.371

CAD, n (%)

55 (44.7)

40 (47.6)

0.681

CVD, n (%)

59 (48.0)

42 (52.0)

0.774

Current smokers, n (%)

61 (49.6)

66 (78.6)

 < 0.001

Past smokers, n (%)

10 (8.1)

13 (15.5)

0.099

Never smoked, n (%)

52 (42.3)

5 (6.0)

 < 0.001

Ankle Brachial Index

0.651

0.528

 < 0.001

Total cholesterol, mg/dL

215.588

224.638

0.004

LDL cholesterol, mg/dL

107.097

120.691

 < 0.001

Triglycerides, mg/dL

172.826

171.779

0.383

Glucose, mg/dL

128.114

127.823

0.832

HbA1C, %

8.832

8.974

0.151

eGFR mL/min/1.73 m2

73.096

72.459

0.67

Omentin-1 ng/mL

31.326

26.024

 < 0.001

  1. BMI Body Mass Index, HBP High Blood Pression, HCHOL Hypercholesterolemia, CAD Coronary Artery Disease, CVD Cerebrovascular Disease, LDL low-density lipoprotein, eGFR estimated glomerular filtration rate. Statistical test performed with Student’s t-test or with Chi square test, when appropriate.